Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma.
Rhabdomyosarcomas (RMSs) are the most common soft tissue sarcomas of childhood and adolescence. To date, there are no effective treatments that target the genetic abnormalities in RMS, and current treatment options for high-risk groups are not adequate. Over the past two decades, research into the molecular mechanisms of RMS has identified key genes and signaling pathways involved in disease pathogenesis. In these studies, members of the receptor tyrosine kinase (RTK) family of cell surface receptors have been characterized as druggable targets for RMS. Through small molecule inhibitors, ligand-neutralizing agents, and monoclonal receptor-blocking antibodies, RTK activity can be manipulated to block oncogenic properties associated with RMS. Herein, we review the members of the RTK family that are implicated in RMS tumorigenesis and discuss both the problems and promise of targeting RTKs in RMS.
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.
Lisa E S
LE
Crose
Corinne M
CM
Linardic
Am J Pathol. 2003 Oct;163(4):1417-28
14507649
Anticancer Drugs. 2007 Nov;18(10):1173-81
17893518
J Cell Biol. 2004 Jul 19;166(2):213-23
15249583
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8318-23
8710868
Genes Chromosomes Cancer. 2010 Mar;49(3):224-36
19953635
J Cell Biol. 1990 Oct;111(4):1623-9
2211828
Cancer Res. 2009 May 1;69(9):3937-46
19366796
Mol Cancer Ther. 2007 May;6(5):1620-8
17483438
Cancer Res. 1991 Oct 15;51(20):5626-31
1680555
Hum Mol Genet. 1994 Jul;3(7):1117-21
7981680
Arch Dis Child. 2003 Apr;88(4):354-7
12651771
Cancer Res. 1994 Nov 1;54(21):5531-4
7923191
Cancer Res. 2005 May 1;65(9):3868-76
15867386
J Clin Oncol. 2006 Feb 10;24(5):816-22
16391296
Cancer Res. 2004 Nov 15;64(22):8428-34
15548714
J Biol Chem. 2006 Jan 6;281(1):429-38
16267055
J Clin Invest. 2009 Aug;119(8):2366-78
19620785
Int J Cancer. 1998 Apr 13;76(2):223-7
9537584
Br J Cancer. 2003 Jul 21;89(2):327-32
12865925
Nature. 1995 Aug 31;376(6543):768-71
7651534
Genes Dev. 2003 Dec 1;17(23):2950-65
14665670
Clin Cancer Res. 2008 Jul 1;14(13):4119-27
18593989
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
20177397
Histopathology. 2009 Jun;54(7):873-9
19469909
Pediatr Blood Cancer. 2008 Mar;50(3):581-7
17457854
Cancer Res. 2009 Oct 1;69(19):7662-71
19789339
J Biol Chem. 2009 Oct 23;284(43):29596-604
19710019
Braz Dent J. 2010 Jan;21(1):68-73
20464324
Nat Med. 2001 Jun;7(6):673-9
11385503
Oncogene. 2008 Nov 20;27(51):6550-60
18679424
Mol Cancer. 2010 Apr 12;9:75
20385023
Mol Cell Biol. 1998 Jul;18(7):4118-30
9632796
Br J Cancer. 1995 Nov;72(5):1224-9
7577472
Oncogene. 1996 Apr 18;12(8):1697-705
8622890
Oncogene. 2007 Mar 22;26(13):1932-40
17001314
Pediatr Blood Cancer. 2010 Jul 1;54(7):921-6
20166202
Br J Cancer. 2009 Dec 15;101(12):2030-7
19888223
Cancer Res. 2003 Aug 15;63(16):5073-83
12941837
Oncogene. 2008 Jun 26;27(28):3923-34
18332870
Cancer Res. 2008 May 1;68(9):3077-80; discussion 3080
18451130
Mod Pathol. 2006 Sep;19(9):1213-20
16729016
Int J Dev Biol. 1997 Aug;41(4):597-605
9303348
Int J Cancer. 2007 Mar 1;120(5):1141-9
17131346
Birth Defects Res C Embryo Today. 2003 Nov;69(4):257-71
14745968
Clin Cancer Res. 2005 Nov 15;11(22):8145-57
16299247
Cancer. 2009 Sep 15;115(18):4218-26
19536876
Nature. 1985 Sep 19-25;317(6034):260-2
2995818
Cancer Res. 2008 Oct 1;68(19):8039-48
18829562
Development. 1994 Mar;120(3):603-12
8162858
Pediatr Blood Cancer. 2010 Dec 1;55(6):1126-33
20672370
Cell. 1993 Oct 8;75(1):59-72
8402901
FEBS Lett. 1999 Oct 1;459(1):100-4
10508925
Clin Cancer Res. 2004 Oct 1;10(19):6750-8
15475466
J Clin Oncol. 2008 Oct 20;26(30):4921-7
18794549
Mol Cancer Ther. 2009 Dec;8(12):3341-9
19996272
Endocr Relat Cancer. 2004 Dec;11(4):689-708
15613446
J Cell Biol. 2006 Aug 28;174(5):677-87
16923828
Genes Chromosomes Cancer. 2007 Nov;46(11):1028-38
17696196
J Immunother. 2010 Apr;33(3):279-86
20445348
Endocr Rev. 1996 Oct;17(5):481-517
8897022
J Clin Oncol. 2002 Jun 1;20(11):2672-9
12039929
Cancer. 2007 Nov 15;110(10):2293-303
17896786
Genomics. 2002 Mar;79(3):278-84
11863357
J Clin Oncol. 2010 Mar 1;28(7):1240-6
20124188
Cancer Res. 2000 Nov 15;60(22):6253-8
11103779
Cancer Res. 2003 Nov 15;63(22):7926-35
14633723
Cancer Res. 1998 Aug 15;58(16):3542-6
9721857
J Clin Invest. 1994 Jul;94(1):445-8
8040287
Cancer Invest. 2006 Apr-May;24(3):310-7
16809160
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4213-8
8633043
Proc Natl Acad Sci U S A. 1987 Feb;84(3):842-6
2433691
Nat Med. 2002 Nov;8(11):1276-80
12368906
J Clin Oncol. 2010 May 1;28(13):2151-8
20351326
Exp Cell Res. 1996 Apr 10;224(1):143-51
8612679
Cancer Res. 2006 May 1;66(9):4742-9
16651427
Int J Cancer. 2000 Jul 1;87(1):29-36
10861449
Development. 2002 Oct;129(19):4559-69
12223412
Oncogene. 2005 Dec 1;24(54):8025-37
16116481
J Clin Invest. 1994 Sep;94(3):1235-42
8083365
Cancer Res. 2010 Aug 15;70(16):6497-508
20663909
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11393-8
12177445
Cancer Res. 2000 Sep 15;60(18):5117-24
11016638
Cell. 2000 Jan 7;100(1):57-70
10647931
Cytokine Growth Factor Rev. 2005 Apr;16(2):139-49
15863030
Cancer Res. 1994 Feb 15;54(4):903-7
7508822
Genes Dev. 2004 Nov 1;18(21):2614-26
15489287
N Engl J Med. 2004 May 20;350(21):2129-39
15118073
J Cell Biol. 1997 Jun 2;137(5):1057-68
9166406
J Clin Invest. 2009 Nov;119(11):3395-407
19809159
J Clin Oncol. 2009 Jul 1;27(19):3148-53
19451433
Cancer Res. 2003 Jun 1;63(11):2728-32
12782574
Biochim Biophys Acta. 1998 Mar 12;1402(1):39-51
9551084
Nature. 2000 Sep 14;407(6801):249-57
11001068
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):701-6
9012848
Cancer Res. 1999 Feb 15;59(4):886-94
10029080
Folia Histochem Cytobiol. 2009 Jan;47(3):485-9
20164036
Cancer Res. 1996 Sep 1;56(17):3898-901
8752155
Cell Mol Life Sci. 2003 Dec;60(12):2721-35
14685695
Cancer Gene Ther. 2008 Jul;15(7):413-48
18404164
Cell Growth Differ. 1990 Jul;1(7):325-31
2177632
Mod Pathol. 2001 May;14(5):506-14
11353062
Genes Chromosomes Cancer. 2007 Apr;46(4):348-58
17243166
Genes Dev. 2008 May 15;22(10):1276-312
18483217
Cancer Res. 2009 Jan 1;69(1):161-70
19117999
Pediatr Blood Cancer. 2006 Mar;46(3):329-38
16261596